We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
-10.74%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$232M
AUM Growth
-$42.5M
Cap. Flow
-$10.5M
Cap. Flow %
-4.52%
Top 10 Hldgs %
40.13%
Holding
56
New
1
Increased
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 28.04%
2 Industrials 18.35%
3 Technology 15.43%
4 Communication Services 10.85%
5 Financials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$609B
$16.2M 6.98%
125,376
-1,855
-1% -$259K
AAPL icon
2
Apple
AAPL
$4.9T
$11.7M 5.04%
296,140
PYPL icon
3
PayPal
PYPL
$49.9B
$11.2M 4.82%
132,850
MA icon
4
Mastercard
MA
$480B
$10.7M 4.61%
56,640
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.23T
$8.26M 3.56%
158,100
WM icon
6
Waste Management
WM
$96.1B
$7.62M 3.29%
85,625
XLNX
7
DELISTED
Xilinx Inc
XLNX
$7.61M 3.28%
89,290
NSC icon
8
Norfolk Southern
NSC
$76.4B
$6.73M 2.9%
45,000
-11,185
-20% -$1.84M
ADI icon
9
Analog Devices
ADI
$183B
$6.63M 2.86%
77,270
DHR icon
10
Danaher
DHR
$144B
$6.48M 2.8%
70,900
DIS icon
11
Walt Disney
DIS
$170B
$6.43M 2.77%
58,625
ROK icon
12
Rockwell Automation
ROK
$51.4B
$6.33M 2.73%
42,070
XYL icon
13
Xylem
XYL
$29.2B
$6.25M 2.69%
93,625
ATR icon
14
AptarGroup
ATR
$8.46B
$6.14M 2.65%
65,275
BSX icon
15
Boston Scientific
BSX
$65.4B
$5.87M 2.53%
166,015
ABT icon
16
Abbott
ABT
$175B
$5.49M 2.37%
75,850
ADP icon
17
Automatic Data Processing
ADP
$102B
$5.45M 2.35%
41,590
MMM icon
18
3M
MMM
$83.4B
$5.33M 2.3%
33,488
PG icon
19
Procter & Gamble
PG
$349B
$5.15M 2.22%
56,025
-8,975
-14% -$802K
NKE icon
20
Nike
NKE
$64.9B
$5.05M 2.18%
68,110
ILMN icon
21
Illumina
ILMN
$28.2B
$4.74M 2.04%
16,242
MRK icon
22
Merck
MRK
$315B
$4.71M 2.03%
64,662
-14,436
-18% -$1.02M
AVGO icon
23
Broadcom
AVGO
$1.76T
$4.66M 2.01%
183,350
NYT icon
24
New York Times
NYT
$12.3B
$4.34M 1.87%
194,650
PFE icon
25
Pfizer
PFE
$143B
$4.17M 1.8%
100,657
-17,387
-15% -$722K

Similar funds

Chad R. Baker's Q4 2018 Portfolio in Review

As of Q4 2018, Chad R. Baker held 56 positions worth $232M, down 15% from $274M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Chad R. Baker withdrew a net $10.5M in Q4 2018, closing 3 positions and reducing 8 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $2.28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.

Against the trend, Chad R. Baker opened a new position in Cigna worth $1.11M.

  • Chad R. Baker's largest Q4 2018 buy was Cigna: 5,841 shares worth $1.11M.
  • Chad R. Baker's biggest Q4 2018 reduction was Norfolk Southern, cutting an estimated $1.84M.
  • Chad R. Baker fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $2.28M.
  • Chad R. Baker's ten largest holdings make up 40% of its $232M portfolio in Q4 2018.
  • Chad R. Baker opened 1 new position and closed 3 in Q4 2018.
  • Chad R. Baker's portfolio value fell 15% quarter-over-quarter to $232M.

Based on Chad R. Baker's 13F filing for Q4 2018, filed 8 Feb 2019.